{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The pharmaceutical industry is beginning to reap a windfall from a surprisingly lucrative niche market: drugs for poor people.", "headline": {"main": "A Windfall From Shifts to Medicare", "kicker": "Market Place", "print_headline": "A Windfall From Shifts To Medicare", "content_kicker": "Market Place"}, "abstract": null, "print_page": "1", "word_count": "1453", "_id": "54ae8ccb7988105cf60961ed", "snippet": "The pharmaceutical industry is beginning to reap a windfall from a surprisingly lucrative niche market: drugs for poor people.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/07/18/business/18place.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicaid", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicare", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "GlaxoSmithKline", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "AstraZeneca", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Bristol Myers Squibb Co", "is_major": "N", "rank": "7", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2006-07-18T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 1, "offset": 0, "time": 29}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}